You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Timeline
Mendeley readers
Chapter title |
The Role of New Oral Anticoagulants (NOACs) in Cancer Patients
|
---|---|
Chapter number | 112 |
Book title |
Thrombosis and Embolism: from Research to Clinical Practice
|
Published in |
Advances in experimental medicine and biology, September 2016
|
DOI | 10.1007/5584_2016_112 |
Pubmed ID | |
Book ISBNs |
978-3-31-922107-6, 978-3-31-922108-3
|
Authors |
Raveena Ravikumar, Chung Sim Lim, Alun Huw Davies |
Editors |
Md. Shahidul Islam |
Abstract |
New oral anticoagulants (NOACs) are likely to have a major impact in the next few years, changing clinical practice of anticoagulation therapy. Evidence on its efficacy and superiority to vitamin K antagonists (VKAs) in treating non-cancer patients have been reported in a few clinical trials. However, patients with cancer are complicated by the prothrombotic nature of the disease, need for potentially invasive surgery and interventions, and altered drug handling. This chapter examines the available evidence and guidelines on the use of NOAC in patients with cancer. |
Mendeley readers
The data shown below were compiled from readership statistics for 36 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 36 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Other | 5 | 14% |
Student > Ph. D. Student | 4 | 11% |
Student > Bachelor | 3 | 8% |
Researcher | 2 | 6% |
Student > Postgraduate | 2 | 6% |
Other | 4 | 11% |
Unknown | 16 | 44% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 12 | 33% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 8% |
Nursing and Health Professions | 1 | 3% |
Business, Management and Accounting | 1 | 3% |
Sports and Recreations | 1 | 3% |
Other | 1 | 3% |
Unknown | 17 | 47% |